Disruption of the β-catenin destruction complex via Ephexin1-Axin1 interaction promotes colorectal cancer proliferation

Abstract Wnt signaling is essential for cell growth and tumor formation and is abnormally activated in colorectal cancer (CRC), contributing to tumor progression; however, the specific role and regulatory mechanisms involved in tumor development remain unclear. Here, we show that Ephexin1, a guanine...

Full description

Saved in:
Bibliographic Details
Main Authors: Jeeho Kim, Young Jin Jeon, In-Youb Chang, Jung-Hee Lee, Ho Jin You
Format: Article
Language:English
Published: Nature Publishing Group 2025-01-01
Series:Experimental and Molecular Medicine
Online Access:https://doi.org/10.1038/s12276-024-01381-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825197467205894144
author Jeeho Kim
Young Jin Jeon
In-Youb Chang
Jung-Hee Lee
Ho Jin You
author_facet Jeeho Kim
Young Jin Jeon
In-Youb Chang
Jung-Hee Lee
Ho Jin You
author_sort Jeeho Kim
collection DOAJ
description Abstract Wnt signaling is essential for cell growth and tumor formation and is abnormally activated in colorectal cancer (CRC), contributing to tumor progression; however, the specific role and regulatory mechanisms involved in tumor development remain unclear. Here, we show that Ephexin1, a guanine nucleotide exchange factor, is significantly overexpressed in CRC and is correlated with increased Wnt/β-catenin pathway activity. Through comprehensive analysis, including RNA sequencing data from TCGA and functional assays, we observed that Ephexin1 promotes tumor proliferation and migration by activating the Wnt/β-catenin pathway. This effect was mediated by the interaction of Ephexin1 with Axin1, a critical component of the β-catenin destruction complex, which in turn enhanced the stability and activity of β-catenin in signaling pathways critical for tumor development. Importantly, our findings also suggest that targeting Ephexin1 may increase the efficacy of Wnt/β-catenin pathway inhibitors in CRC treatment. These findings highlight the potential of targeting Ephexin1 as a strategy for developing effective treatments for CRC, suggesting a novel and promising approach to therapy aimed at inhibiting cancer progression.
format Article
id doaj-art-e6bc391676bc429793933d5a8219ac1e
institution Kabale University
issn 2092-6413
language English
publishDate 2025-01-01
publisher Nature Publishing Group
record_format Article
series Experimental and Molecular Medicine
spelling doaj-art-e6bc391676bc429793933d5a8219ac1e2025-02-09T12:14:08ZengNature Publishing GroupExperimental and Molecular Medicine2092-64132025-01-0157115116610.1038/s12276-024-01381-1Disruption of the β-catenin destruction complex via Ephexin1-Axin1 interaction promotes colorectal cancer proliferationJeeho Kim0Young Jin Jeon1In-Youb Chang2Jung-Hee Lee3Ho Jin You4Laboratory of Genomic Instability and Cancer TherapeuticsDepartment of PharmacologyDepartment of AnatomyLaboratory of Genomic Instability and Cancer TherapeuticsLaboratory of Genomic Instability and Cancer TherapeuticsAbstract Wnt signaling is essential for cell growth and tumor formation and is abnormally activated in colorectal cancer (CRC), contributing to tumor progression; however, the specific role and regulatory mechanisms involved in tumor development remain unclear. Here, we show that Ephexin1, a guanine nucleotide exchange factor, is significantly overexpressed in CRC and is correlated with increased Wnt/β-catenin pathway activity. Through comprehensive analysis, including RNA sequencing data from TCGA and functional assays, we observed that Ephexin1 promotes tumor proliferation and migration by activating the Wnt/β-catenin pathway. This effect was mediated by the interaction of Ephexin1 with Axin1, a critical component of the β-catenin destruction complex, which in turn enhanced the stability and activity of β-catenin in signaling pathways critical for tumor development. Importantly, our findings also suggest that targeting Ephexin1 may increase the efficacy of Wnt/β-catenin pathway inhibitors in CRC treatment. These findings highlight the potential of targeting Ephexin1 as a strategy for developing effective treatments for CRC, suggesting a novel and promising approach to therapy aimed at inhibiting cancer progression.https://doi.org/10.1038/s12276-024-01381-1
spellingShingle Jeeho Kim
Young Jin Jeon
In-Youb Chang
Jung-Hee Lee
Ho Jin You
Disruption of the β-catenin destruction complex via Ephexin1-Axin1 interaction promotes colorectal cancer proliferation
Experimental and Molecular Medicine
title Disruption of the β-catenin destruction complex via Ephexin1-Axin1 interaction promotes colorectal cancer proliferation
title_full Disruption of the β-catenin destruction complex via Ephexin1-Axin1 interaction promotes colorectal cancer proliferation
title_fullStr Disruption of the β-catenin destruction complex via Ephexin1-Axin1 interaction promotes colorectal cancer proliferation
title_full_unstemmed Disruption of the β-catenin destruction complex via Ephexin1-Axin1 interaction promotes colorectal cancer proliferation
title_short Disruption of the β-catenin destruction complex via Ephexin1-Axin1 interaction promotes colorectal cancer proliferation
title_sort disruption of the β catenin destruction complex via ephexin1 axin1 interaction promotes colorectal cancer proliferation
url https://doi.org/10.1038/s12276-024-01381-1
work_keys_str_mv AT jeehokim disruptionofthebcatenindestructioncomplexviaephexin1axin1interactionpromotescolorectalcancerproliferation
AT youngjinjeon disruptionofthebcatenindestructioncomplexviaephexin1axin1interactionpromotescolorectalcancerproliferation
AT inyoubchang disruptionofthebcatenindestructioncomplexviaephexin1axin1interactionpromotescolorectalcancerproliferation
AT jungheelee disruptionofthebcatenindestructioncomplexviaephexin1axin1interactionpromotescolorectalcancerproliferation
AT hojinyou disruptionofthebcatenindestructioncomplexviaephexin1axin1interactionpromotescolorectalcancerproliferation